BMM
GILD icon

Buffington Mohr McNeal’s Gilead Sciences GILD Stock Holding History

Buffington Mohr McNeal’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,200
Closed -$158K – 116
2016
Q4 		$158K Buy
2,200
+250
+13% +$18.6K 0.06% 130
2016
Q3 		$154K Sell
1,950
-100
-5% -$8.12K 0.06% 123
2016
Q2 		$171K Hold
2,050
– – 0.08% 121
2016
Q1 		$188K Buy
+2,050
New +$185K 0.08% 128

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Buffington Mohr McNeal's GILD Position: Q1 2017 in Review

Buffington Mohr McNeal sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 2,200 shares — an estimated $158K sold.

Buffington Mohr McNeal first reported a position in GILD in Q1 2016 and held it in 4 quarters. The position peaked at $188K in Q1 2016. 1,525 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Buffington Mohr McNeal reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • Buffington Mohr McNeal sold 2,200 Gilead Sciences shares in Q1 2017, an estimated $158K.
  • Buffington Mohr McNeal first reported a position in Gilead Sciences in Q1 2016 and held it in 4 quarters.
  • Buffington Mohr McNeal's Gilead Sciences position peaked at $188K in Q1 2016.
  • 1,525 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Buffington Mohr McNeal's 13F filing for Q1 2017, filed 3 May 2017.